![]() |
|
|
Vol. 301, Issue 3, 838-851, June 2002
Maxine Dunitz Neurosurgical Institute and Burns and Allen Research
Institute (N.N.,M.R.,K.H.,K.B.), Confocal Microscopy Facility, and
Atherosclerosis Research Center, Division of Cardiology (K.A.),
Cedars-Sinai Medical Center, Los Angeles, California
The blood-brain tumor barrier (BTB) limits the delivery of therapeutic
drugs to brain tumors. We demonstrate in a rat brain tumor (RG2) model
an enhanced drug delivery to brain tumor following intracarotid
infusion of bradykinin (BK), nitric oxide (NO) donors, or agonists of
soluble guanylate cyclase (sGC) and calcium-dependent potassium
(KCa) channels. We modulated KCa channels by
specific agonists and agents that produce NO and cGMP in situ to obtain sustained enhancement of selective drug delivery to brain tumors. Intracarotid infusion of BK or
1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one (NS-1619) significantly enhanced BTB permeability
(Ki) to
[14C]
-aminoisobutyric acid in the brain tumor area but
not in normal brain tissue. The Ki increase
achieved by BK, NS-1619, NO donors, or the sGC activator
3-(5'-hydroxymethyl-2'furyl)-1-benzylindazole (YC-1) was significantly
attenuated when coinfused with a KCa channel antagonist,
iberiotoxin. Immunoblot and immunolocalization studies
demonstrate overexpression of KCa channels in tumor cells and capillaries compared with normal brain. The potentiometric assays
demonstrate the functional activity of KCa channels in rat
brain endothelial and glioma cells. Additionally, we show that BK and
NS-1619 significantly increased the density of transport vesicles in
the cytoplasm of brain tumor capillary endothelia and tumor cells. The
cleft indices and cleft area indices in rat tumor capillaries were
significantly higher than in normal brain capillaries, and BK infusion
did not alter these indices. These data demonstrate that the cellular
mechanism for KCa channel-mediated BTB permeability
increase is due to accelerated formation of pinocytotic vesicles, which
can transport drugs across BTB. We conclude that KCa
channels serve as a convergence point in the biochemical regulation of
BTB permeability.
This article has been cited by other articles:
![]() |
D. Yin, X. Wang, B. M. Konda, J. M. Ong, J. Hu, M. R. Sacapano, M. K. Ko, A. J. Espinoza, D. K. Irvin, Y. Shu, et al. Increase in Brain Tumor Permeability in Glioma-Bearing Rats with Nitric Oxide Donors Clin. Cancer Res., June 15, 2008; 14(12): 4002 - 4009. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Weaver, M. L. Olsen, M. B. McFerrin, and H. Sontheimer BK Channels Are Linked to Inositol 1,4,5-Triphosphate Receptors via Lipid Rafts: A NOVEL MECHANISM FOR COUPLING [Ca2+]i TO ION CHANNEL ACTIVATION J. Biol. Chem., October 26, 2007; 282(43): 31558 - 31568. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yamazaki, M. Aoyama, S. Ohya, K. Muraki, K. Asai, and Y. Imaizumi Novel Functions of Small Conductance Ca2+-activated K+ Channel in Enhanced Cell Proliferation by ATP in Brain Endothelial Cells J. Biol. Chem., December 15, 2006; 281(50): 38430 - 38439. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Ningaraj, M. K. Rao, and K. L. Black Adenosine 5'-triphosphate-sensitive Potassium Channel-mediated Blood-Brain Tumor Barrier Permeability Increase in a Rat Brain Tumor Model Cancer Res., December 15, 2003; 63(24): 8899 - 8911. [Abstract] [Full Text] [PDF] |
||||